Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)

NCT02583256 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1601

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Adjuvanted QIV (aQIV)
BIOLOGICAL: Non-adjuvanted QIV

Sponsor

Seqirus